STOCK TITAN

Humacyte Warrant (HUMAW) Revenue by Year

HUMAW

Humacyte, Inc. Warrant generated $2.0M in revenue in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $2.1M in revenue. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Humacyte, Inc. Warrant has filed alongside them.

FY2025 annual
Revenue $2.0M
YoY n/m
Source SEC Filings Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HUMAW Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Revenue$2.1M$2.0Mn/m$0N/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

HUMAW Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'25FilingQ2'2510-QQ1'2510-QQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23FilingQ3'23Filing
Revenue$406K+34.9%$495K-4.3%$467Kn/m$753Kn/m$301Kn/m$517Kn/m$0$0$0$0N/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Humacyte, Inc. Warrant financials

Frequently Asked Questions

Humacyte, Inc. Warrant generated $2.0M in revenue in fiscal year 2025.

Humacyte, Inc. Warrant (HUMAW) reported $0 in revenue in fiscal year 2024 and $2.0M in revenue in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Humacyte, Inc. Warrant (HUMAW) reported $2.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Humacyte, Inc. Warrant (HUMAW) reported $406K in revenue in Q2 2026. This represents an increase of 34.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Humacyte, Inc. Warrant (HUMAW) reported on that line in every period on record.